Mark A. Geyer

44.4k total citations · 5 hit papers
443 papers, 34.5k citations indexed

About

Mark A. Geyer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Mark A. Geyer has authored 443 papers receiving a total of 34.5k indexed citations (citations by other indexed papers that have themselves been cited), including 256 papers in Cellular and Molecular Neuroscience, 125 papers in Molecular Biology and 120 papers in Cognitive Neuroscience. Recurrent topics in Mark A. Geyer's work include Neurotransmitter Receptor Influence on Behavior (205 papers), Neuroscience and Neuropharmacology Research (129 papers) and Receptor Mechanisms and Signaling (101 papers). Mark A. Geyer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (205 papers), Neuroscience and Neuropharmacology Research (129 papers) and Receptor Mechanisms and Signaling (101 papers). Mark A. Geyer collaborates with scholars based in United States, Netherlands and United Kingdom. Mark A. Geyer's co-authors include Neal R. Swerdlow, David Braff, Jared W. Young, Martin P. Paulus, Franz X. Vollenweider, Adam L. Halberstadt, Susan B. Powell, Victoria B. Risbrough, Stephanie C. Dulawa and William Perry and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Mark A. Geyer

439 papers receiving 33.7k citations

Hit Papers

Human studies of prepulse... 1978 2026 1994 2010 2001 2008 1978 2001 1998 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark A. Geyer 18.4k 9.5k 9.4k 6.3k 5.0k 443 34.5k
Klaus‐Peter Lesch 18.0k 1.0× 8.1k 0.9× 10.4k 1.1× 7.8k 1.2× 7.3k 1.5× 635 42.3k
Dennis L. Murphy 17.3k 0.9× 7.1k 0.7× 9.8k 1.0× 7.1k 1.1× 9.5k 1.9× 572 40.9k
Neal R. Swerdlow 13.6k 0.7× 9.0k 0.9× 6.5k 0.7× 4.6k 0.7× 2.2k 0.4× 321 24.6k
Anthony A. Grace 22.4k 1.2× 14.3k 1.5× 9.2k 1.0× 4.4k 0.7× 2.0k 0.4× 350 35.3k
Patrick R. Hof 12.5k 0.7× 15.0k 1.6× 10.8k 1.1× 5.9k 0.9× 1.2k 0.2× 664 48.1k
René Hen 23.6k 1.3× 10.6k 1.1× 14.5k 1.5× 2.6k 0.4× 2.5k 0.5× 326 49.2k
David A. Lewis 22.9k 1.2× 15.6k 1.6× 14.6k 1.6× 5.1k 0.8× 1.6k 0.3× 565 46.0k
Joseph L. Price 14.7k 0.8× 19.9k 2.1× 4.5k 0.5× 8.2k 1.3× 1.8k 0.4× 179 41.9k
Bhaskar Kolachana 8.1k 0.4× 8.9k 0.9× 4.2k 0.4× 5.1k 0.8× 3.1k 0.6× 104 22.6k
David Braff 9.0k 0.5× 10.5k 1.1× 4.8k 0.5× 7.3k 1.2× 2.6k 0.5× 231 23.6k

Countries citing papers authored by Mark A. Geyer

Since Specialization
Citations

This map shows the geographic impact of Mark A. Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Geyer more than expected).

Fields of papers citing papers by Mark A. Geyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Geyer. The network helps show where Mark A. Geyer may publish in the future.

Co-authorship network of co-authors of Mark A. Geyer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Geyer. A scholar is included among the top collaborators of Mark A. Geyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Geyer. Mark A. Geyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piomelli, Daniele, Kwang‐Mook Jung, Samuel A. Barnes, et al.. (2025). Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participants. Translational Psychiatry. 15(1). 506–506.
2.
Geyer, Mark A., et al.. (2025). Effect of blast exposure on sensorimotor gating and fear memory. Physiology & Behavior. 300. 115029–115029.
3.
Geyer, Mark A.. (2023). A Brief Historical Overview of Psychedelic Research. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 9(5). 464–471. 15 indexed citations
4.
Achim, Cristian L., et al.. (2022). iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression. Pharmacology Biochemistry and Behavior. 222. 173499–173499. 3 indexed citations
6.
Hendricks, Peter S., Charles D. Nichols, Kathryn A. Cunningham, et al.. (2022). Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion. PubMed. 1(1). 2–11. 1 indexed citations
7.
Walter, T. Jordan, et al.. (2020). The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review. Archives of Clinical Neuropsychology. 36(5). 673–685. 18 indexed citations
8.
Yurgil, Kate A., Royce E. Clifford, Victoria B. Risbrough, et al.. (2015). Prospective Associations Between Traumatic Brain Injury and Postdeployment Tinnitus in Active-Duty Marines. Journal of Head Trauma Rehabilitation. 31(1). 30–39. 15 indexed citations
9.
Acheson, Dean T., Murray B. Stein, Martin P. Paulus, Mark A. Geyer, & Victoria B. Risbrough. (2012). The effect of pregabalin on sensorimotor gating in ‘low’ gating humans and mice. Neuropharmacology. 63(3). 480–485. 15 indexed citations
10.
Halberstadt, Adam L. & Mark A. Geyer. (2011). Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 61(3). 364–381. 293 indexed citations
11.
Quednow, Boris B., Michael Kometer, Mark A. Geyer, & Franz X. Vollenweider. (2011). Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers. Neuropsychopharmacology. 37(3). 630–640. 172 indexed citations
12.
Risbrough, Victoria B., Sarah C. Coste, Mary P. Stenzel‐Poore, et al.. (2007). Role of CRF-R1 and CRF-R2 receptors in unconditioned and conditioned fear-induced increases in startle. Biological Psychiatry. 61. 1 indexed citations
13.
Ludewig, S., Katja Ludewig, Mark A. Geyer, Daniel Hell, & Franz X. Vollenweider. (2002). Prepulse inhibition deficits in patients with panic disorder. Depression and Anxiety. 15(2). 55–60. 132 indexed citations
14.
Braff, David, Mark A. Geyer, Gregory A. Light, et al.. (2001). Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research. 49(1-2). 171–178. 237 indexed citations
15.
Bakshi, Vaishali P., Mark D. Tricklebank, H.C. Neijt, Virginia Lehmann-Masten, & Mark A. Geyer. (1999). Disruption of Prepulse Inhibition and Increases in Locomotor Activity by Competitive N-Methyl-d-aspartate Receptor Antagonists in Rats. Journal of Pharmacology and Experimental Therapeutics. 288(2). 643–652. 50 indexed citations
16.
Grailhe, Régis, Christian Waeber, Stephanie C. Dulawa, et al.. (1999). Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor. Neuron. 22(3). 581–591. 138 indexed citations
17.
Geyer, Mark A., Lawrence S. Wilkinson, Trevor Humby, & Trevor W. Robbins. (1993). Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biological Psychiatry. 34(6). 361–372. 317 indexed citations
18.
Caine, S. Barak, Mark A. Geyer, & Neal R. Swerdlow. (1991). Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat. Psychopharmacology. 105(3). 347–354. 89 indexed citations
19.
Callaway, Clifton W., et al.. (1990). Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 456–464. 152 indexed citations
20.
Gold, Lisa, George F. Koob, & Mark A. Geyer. (1988). Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.. Journal of Pharmacology and Experimental Therapeutics. 247(2). 547–555. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026